H-Index
38
Scimago Lab
powered by Scopus
JCR
Clarivate
Analytics
call: +1.631.629.4327
Mon-Fri 10 am - 2 pm EST

Logo

MSMbanner
Medical Science Monitor Basic Research

AmJCaseRep
MedSciTechnol

eISSN: 2329-0358

Hyperhomocysteinemia as A Risk Factorfor Cardiovascular Diseases.The Association of Hyperhomocysteinemia with Diabetes Mellitus and Renal Transplant Recipients

Marcin W Socha, Malgorzata J Polakowska, Koryna Socha-Urbanek, Piotr Fiedor

Ann Transplant 1999; 4(1): 11-19

ID: 497432

Available online:

Published: 1999-03-12


Hyperhomocysteinemia has been recognised as an independent risk factor for cardiovascular, cerebrovascular and peripheral artery disease. There is strong evidence suggesting that hyperhomocysteinemia accelerates the process of atherogenesis. Possible explanations for this will be shortly reviewed. Recently a growing interest has been focused on the association of hyperhomocysteinemia with diabetes mellitus and with chronic renal disease, including renal transplant recipients. Some clinicalaspects of this occurrence, such as interactions with insulin, metformin, and cyclosporine and also with some vitamins, will be described. The issue of hyperhomocysteinemia in heart transplant patients will also be mentioned. Last of all, the interaction of homocysteine concentration with some beverages will be considered.

Keywords: homocysteine, Hyperhomocysteinemia, Diabetes Mellitus, Organ Transplantation



Back